Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B412565-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $29.90 | |
B412565-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $121.90 | |
B412565-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $199.90 | |
B412565-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $399.90 | |
B412565-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $629.90 | |
B412565-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $999.90 |
DNA/RNA Synthesis Inhibitors
Specifications & Purity | ≥98% |
---|---|
Biochemical and Physiological Mechanisms | Brr2 inhibitor C9 (Brr2 Inhibitor 9) is an allosteric inhibitor of the spliceosomal RNA helicase Brr2. Brr2 is implicated in autosomal-dominant retinitis pigmentosa a group of progressive retinal degenerative disorders. |
Storage Temp | Protected from light,Store at -20°C |
Shipped In | Ice chest + Ice pads |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 6-benzyl-3-[3-(1,3-thiazol-5-ylmethoxy)phenyl]-1,4-dihydropyrido[4,3-d]pyrimidine-2,7-dione |
---|---|
INCHI | InChI=1S/C24H20N4O3S/c29-23-10-22-18(13-27(23)12-17-5-2-1-3-6-17)14-28(24(30)26-22)19-7-4-8-20(9-19)31-15-21-11-25-16-32-21/h1-11,13,16H,12,14-15H2,(H,26,30) |
InChi Key | GAWVULNDIBAUHU-UHFFFAOYSA-N |
Canonical SMILES | C1C2=CN(C(=O)C=C2NC(=O)N1C3=CC(=CC=C3)OCC4=CN=CS4)CC5=CC=CC=C5 |
Isomeric SMILES | C1C2=CN(C(=O)C=C2NC(=O)N1C3=CC(=CC=C3)OCC4=CN=CS4)CC5=CC=CC=C5 |
PubChem CID | 132585219 |
Molecular Weight | 444.51 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2402101 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402102 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402103 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402104 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402105 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402106 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402107 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402108 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402109 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402110 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402111 | Certificate of Analysis | Dec 29, 2023 | B412565 |
B2402112 | Certificate of Analysis | Dec 29, 2023 | B412565 |
Solubility | Solubility (25°C) In vitro DMSO: 89 mg/mL (200.22 mM); Ethanol: 2 mg/mL (4.49 mM); Water: Insoluble; |
---|---|
Sensitivity | Light sensitive |